Clinical Trials Browser

Phase 2 × Castration-Resistant Prostate Carcinoma × tetracarboxyphenylporphine × Clear all

NCT03516812 2025-09-29

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

Phase 2 Completed

36 enrolled 14 charts

Castration-Resistant Prostate Carcinoma